Efficacy and Tolerability of Intravenous Ferric Carboxymaltose in Patients with Iron Deficiency at a Hospital Outpatient Clinic: A Retrospective Cohort Study of Real-World Clinical Practice

Ferric carboxymaltose (FCM) is an intravenous iron formulation to correct iron deficiency. Although its use has been extensively studied in clinical trials, real-world evidence regarding FCM treatment is scarce. Our aim was to evaluate the efficacy and tolerability of FCM treatment in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Robalo Nunes, António, Palricas Costa, Ana, Rocha, Sara Lemos, Garcia de Oliveira, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512038/
https://www.ncbi.nlm.nih.gov/pubmed/28758033
http://dx.doi.org/10.1155/2017/3106890

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512038/
https://www.ncbi.nlm.nih.gov/pubmed/28758033
http://dx.doi.org/10.1155/2017/3106890

Ejemplares similares